FormFactor looks like a quality semiconductor name that just got dragged down by sector emotion instead of company-specific deterioration. The bull case is simple: this business is already showing real AI-linked demand, not just talking about it, with Q1 revenue up 32.0% year over year to a record $226.1 million and management explicitly tying that strength to HBM applications. When a company posts record sales, expands margins, and then gets hit in a broader AI selloff, that usually creates opportunity rather than a warning sign. We think FORM has become one of the easier rebound cases in the group ahead of its next earnings catalyst.
The most important point here is that the growth is already on the income statement. FormFactor’s April quarter was its second straight all-time revenue record, and it wasn’t driven by vague future hopes; management called out increased DRAM demand in HBM applications and growth in networking-related probe cards. That matters because the market is rewarding real AI infrastructure exposure, and FORM is supplying a critical piece of that stack. The next report matters too, with consensus looking for roughly $244.8 million in Q2 revenue, which would keep the growth story moving rather than stalling.
Margins make the story stronger. Non-GAAP gross margin improved by 510 basis points sequentially in Q1 and landed 250 basis points above the high end of guidance, a sign that this is not just a volume story but an operating leverage story. Investor Day added another layer of credibility with a framework targeting more than 1,400 basis points of gross margin improvement over time, tied to HBM, advanced packaging, and co-packaged optics. That is exactly the kind of roadmap investors want from a semiconductor equipment name: current demand strength paired with a believable path to better economics.
The balance sheet and execution profile also help explain why this is a rebound candidate instead of a falling knife. FORM’s TickerSpark Score sits at 57 overall, which is only middling at first glance, but the composition matters: Financial Health is an elite 96 and Profitability is 65. The company has also beaten earnings estimates in five of the last seven quarters, including a 27.3% beat in April and a 31.4% beat in February. Add in strongly positive recent news sentiment and a Buy consensus with 10 buys against 8 holds and 1 sell, and the setup looks much more like post-rally digestion than a broken thesis.
The cleanest knock on FORM is valuation. A 120.45x trailing P/E and 64.79x EV/EBITDA are rich by any standard, and the TickerSpark Score’s Valuation component at 37 makes clear that this is not a cheap stock hiding in plain sight. The technical picture is also ugly in the near term, with the shares below both the 20-day and 50-day moving averages and an RSI of 39 showing that momentum has cooled fast after a huge run.
That risk is real, but it does not outweigh the operating evidence. The market may be compressing the multiple because it wants more clarity on what growth looks like exiting 2026, and insider selling of $1.87 million across recent transactions does not help sentiment. Even so, this is still a stock up 78.8% year to date versus 23.0% for the technology sector, and that outperformance was earned by execution. When a premium multiple meets premium demand signals, we would rather own the pullback than chase a cheaper semiconductor name with weaker AI linkage.
That leaves FORM looking like a buy-the-dip name into the next earnings report, not a stock to abandon because the chart got hit. We’d be watching one thing above all: whether Q2 again shows HBM-driven demand translating into revenue growth and sustained margin strength. If FormFactor delivers another quarter that supports the April narrative, the recent selloff should look like a reset in sentiment rather than the start of a deeper unwind.
We would still respect the risk because this is not a low-multiple safety trade. If the next report shows growth decelerating sharply or margins giving back the Q1 improvement, the premium setup breaks fast. Until that happens, the combination of record revenue, 510-basis-point gross margin expansion, and a strong Financial Health profile keeps the rebound case intact.
